Version 1
: Received: 6 April 2023 / Approved: 6 April 2023 / Online: 6 April 2023 (11:11:37 CEST)
Version 2
: Received: 5 May 2023 / Approved: 5 May 2023 / Online: 5 May 2023 (11:16:36 CEST)
Blair R. Hesp, Katsuhisa Arai, Namita Bose, Rachael Profit, Malvika Katarya, Jonathan Lee, Ronnie Lin, Magdalene Chu, Andrew Sakko & Hazel Fernandez (2023) Applying the good publication practice 2022 guidelines in the Asia-Pacific region: a practical guide, Current Medical Research and Opinion, 39:6, 919-931, DOI: 10.1080/03007995.2023.2214433
Blair R. Hesp, Katsuhisa Arai, Namita Bose, Rachael Profit, Malvika Katarya, Jonathan Lee, Ronnie Lin, Magdalene Chu, Andrew Sakko & Hazel Fernandez (2023) Applying the good publication practice 2022 guidelines in the Asia-Pacific region: a practical guide, Current Medical Research and Opinion, 39:6, 919-931, DOI: 10.1080/03007995.2023.2214433
Blair R. Hesp, Katsuhisa Arai, Namita Bose, Rachael Profit, Malvika Katarya, Jonathan Lee, Ronnie Lin, Magdalene Chu, Andrew Sakko & Hazel Fernandez (2023) Applying the good publication practice 2022 guidelines in the Asia-Pacific region: a practical guide, Current Medical Research and Opinion, 39:6, 919-931, DOI: 10.1080/03007995.2023.2214433
Blair R. Hesp, Katsuhisa Arai, Namita Bose, Rachael Profit, Malvika Katarya, Jonathan Lee, Ronnie Lin, Magdalene Chu, Andrew Sakko & Hazel Fernandez (2023) Applying the good publication practice 2022 guidelines in the Asia-Pacific region: a practical guide, Current Medical Research and Opinion, 39:6, 919-931, DOI: 10.1080/03007995.2023.2214433
Abstract
Objective: The Asia-Pacific region (APAC) represents a unique environment for the publication of biomedical research, particularly industry-funded research. Awareness and adoption of international guidelines on ethical publication practices continues to increase across APAC, but the reframing and expansion of many of the recommendations in the Good Publication Practice (GPP) 2022 guidelines versus GPP3 published in 2015 have important implications for publishing industry-funded biomedical research in the region. Methods: This manuscript provides practical guidance for stakeholders in APAC on interpreting and applying the recommendations made in the GPP 2022 guidelines. Results: Key focus areas include navigating new opportunities for communicating industry-funded research, such as plain language summaries, social media, and preprints; implementing formal processes to improve the integrity of published research in APAC; and methods of promoting transparency and inclusion when publishing industry-funded research. Key APAC-specific issues, including encore presentations, leadership on publication ethics in the region, access to professional resources, and support for educating regional stakeholders are also discussed. Conclusions: Overall, this review offers a pragmatic guide for stakeholders in industry-sponsored research on applying GPP 2022 in practice with a focus on effectively integrating these guidelines in an APAC context.
Keywords
Asia-Pacific; Authorship; Conflict of interest; Disclosures; Ethics; Good Publication Practice; Manuscript development
Subject
Medicine and Pharmacology, Other
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Commenter: Blair Hesp
Commenter's Conflict of Interests: Author